Pflug Koory, LLC United Therapeutics Corp Transaction History

Pflug Koory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$166.16 - $213.96 $12,462 - $16,047	-75 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$179.86 - $214.88 $80,937 - $96,696	-450 Reduced 85.71%	75 $14,000
Q2 2021 Jul 14, 2021	BUY	$170.47 - $211.93 $42,617 - $52,982	250 Added 90.91%	525 $94,000
Q1 2021 Jul 13, 2021	SELL	$153.94 - $174.85 $38,485 - $43,712	-250 Reduced 47.62%	275 $46,000
Q4 2020 Jan 14, 2021	SELL	$101.87 - $151.79 $10,187 - $15,179	-100 Reduced 16.0%	525 $80,000
Q1 2020 Apr 24, 2020	SELL	$79.39 - $115.35 $3,969 - $5,767	-50 Reduced 7.41%	625 $59,000
Q3 2019 Oct 15, 2019	SELL	$74.85 - $85.99 $9,356 - $10,748	-125 Reduced 15.63%	675 $54,000
Q1 2019 Apr 11, 2019	SELL	$107.15 - $126.84 $8,036 - $9,513	-75 Reduced 8.57%	800 $94,000
Q3 2018 Nov 06, 2018	SELL	$113.81 - $129.46 $45,524 - $51,784	-400 Reduced 31.37%	875 $112,000
Q2 2018 Aug 13, 2018	BUY	$101.14 - $118.31 $40,456 - $47,324	400 Added 45.71%	1,275 $144,000
Q4 2017 Aug 13, 2018	SELL	$118.58 - $151.28 $17,787 - $22,692	-150 Reduced 14.63%	875 $129,000
Q4 2016 Aug 13, 2018	BUY	N/A	1,025	1,025 $147,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Pflug Koory, LLC, based on Form 13F filings with the SEC.

Stay updated on Pflug Koory, LLC with notifications on news.